Infectoazit (Azithromycin Dihydrate)

Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide chain elongation. This bacteriostatic action stops the growth of susceptible bacteria on the ocular surface, allowing the immune system to clear the infection.

The dosing regimen for Infectoazit is determined by the prescribing clinician based on the specific infection, severity, and patient factors. The prescriber will provide detailed instructions on the number of drops, frequency, and duration of therapy.

Safety data for azithromycin ocular use in pregnancy and lactation are limited. Prescribers should weigh potential benefits against risks and consider alternative treatments if there are concerns. Consultation with a healthcare professional is essential.

To order Infectoazit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Infectoazit (azithromycin) offers a broad spectrum against Gram‑positive and Gram‑negative ocular pathogens and has a favorable dosing schedule compared with some fluoroquinolone drops. It is a macrolide, distinct from aminoglycosides or sulfonamides, and may be preferred when resistance to other classes is a concern.

Store Infectoazit at room temperature, below 25 °C, in its original packaging. Protect the container from moisture and direct sunlight. Do not freeze the product, and keep the dropper tip clean to avoid contamination.

Infectoazit is applied as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and instill the prescribed number of drops. Close the eye gently for a few minutes and avoid blinking excessively to allow absorption.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome affecting the eye, and rare cases of significant vision loss or corneal ulceration. Immediate medical attention is required if any of these symptoms develop.

Patients with known hypersensitivity to azithromycin, other macrolides, or any component of the formulation should avoid using Infectoazit. It is also contraindicated in individuals with a history of severe ocular allergic reactions or those for whom a bacterial etiology has not been confirmed.